Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Goff

Showing results (221-230 of 248) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|March 16, 2010
Effects of intensive blood-pressure control in type 2 diabetes mellitus, William C Cushman, Gregory W Evans, et al.
The New England Journal of Medicine|July 1, 2010
Effects of medical therapies on retinopathy progression in type 2 diabetes, , Emily Y Chew, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 10, 2010
Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudyWalter T Ambrosius, Ronald P Danis, David C Goff, et al.
Circulation Research|April 30, 2019
Implementing the National Heart, Lung, and Blood Institute's Strategic Vision in the Division of Cardiovascular Sciences, David C Goff, Denis B Buxton, et al.
The New England Journal of Medicine|March 16, 2010
Effects of combination lipid therapy in type 2 diabetes mellitus, Henry N Ginsberg, Marshall B Elam, et al.
Clinical Trials (London, England)|June 7, 2014
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)Walter T Ambrosius, Kaycee M Sink, Capri G Foy, et al.
The New England Journal of Medicine|November 10, 2015
A Randomized Trial of Intensive versus Standard Blood-Pressure Control, Jackson T Wright, Jeff D Williamson, et al.
JAMA Cardiology|December 29, 2016
Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 DiabetesMarshall B Elam, Henry N Ginsberg, Laura C Lovato, et al.
Clinical Trials (London, England)|February 26, 2016
Recruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention TrialThomas M Ramsey, Joni K Snyder, Laura C Lovato, et al.
Circulation|July 1, 2004
ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation)Robert L McNamara, Lawrence M Brass, Joseph P Drozda, et al.
Pageof 25

Showing results (221-230 of 248) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|March 16, 2010
Effects of intensive blood-pressure control in type 2 diabetes mellitus, William C Cushman, Gregory W Evans, et al.
The New England Journal of Medicine|July 1, 2010
Effects of medical therapies on retinopathy progression in type 2 diabetes, , Emily Y Chew, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 10, 2010
Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudyWalter T Ambrosius, Ronald P Danis, David C Goff, et al.
Circulation Research|April 30, 2019
Implementing the National Heart, Lung, and Blood Institute's Strategic Vision in the Division of Cardiovascular Sciences, David C Goff, Denis B Buxton, et al.
The New England Journal of Medicine|March 16, 2010
Effects of combination lipid therapy in type 2 diabetes mellitus, Henry N Ginsberg, Marshall B Elam, et al.
Clinical Trials (London, England)|June 7, 2014
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)Walter T Ambrosius, Kaycee M Sink, Capri G Foy, et al.
The New England Journal of Medicine|November 10, 2015
A Randomized Trial of Intensive versus Standard Blood-Pressure Control, Jackson T Wright, Jeff D Williamson, et al.
JAMA Cardiology|December 29, 2016
Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 DiabetesMarshall B Elam, Henry N Ginsberg, Laura C Lovato, et al.
Clinical Trials (London, England)|February 26, 2016
Recruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention TrialThomas M Ramsey, Joni K Snyder, Laura C Lovato, et al.
Circulation|July 1, 2004
ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation)Robert L McNamara, Lawrence M Brass, Joseph P Drozda, et al.
Pageof 25